ArticleCancer gene therapy2026

mTORC1/2 inhibition induces tumor regression in CDK4/6 inhibitor-insensitive acral melanoma.

Jeremy A Bravo Narula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.